Stock Detail
NMT MEDICAL INC
Medical Instruments Supls
NMTI @ Yahoo Finance | NMTI Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $0.19 | $0.19 | $0.00 | 0.00% | 0.00 | $0.20 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $0.00 | $0.15 | 67,638 | 0 | 71,547 | -0.33 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 0.22 | 0.21 | 0.18 | 0.17 | 0.14 |
Stock Profile
NMT Medical, Inc. engages in designing, developing, and marketing proprietary implant technologies that allow cardiologists to treat cardiac sources of migraine headaches, stroke, and other brain attacks through minimally invasive, catheter-based procedures. The company designs and develops implants that seal the patent foramen ovale defect. It also offers cardiac septal repair implants delivered with nonsurgical catheter techniques. The company manufactures CardioSEAL, a cardiac septal repair implant; and STARFlex, which incorporates a self-centering system that enables the implant to self-adjust to variations in the anatomy of a septal defect without deforming the septum or interfering with heart valve function. NMT Medical markets CardioSEAL through its direct sales force to customers in the United States and Canada, and markets CardioSEAL and STARFlex directly and through distributors in Europe. In addition, the company sells third party products for use with the CardioSEAL and STARFlex implant devices, principally vascular sizing balloons and sheaths. NMT Medical was co-founded by Morris Simon in 1986 and is headquartered in Boston, Massachusetts.